CAMP4 to Participate in the Piper Sandler 36th Annual Healthcare Conference

CAMBRIDGE, Mass., Dec. 02, 2024 (GLOBE NEWSWIRE) -- CAMP4 Therapeutics Corporation (“CAMP4”) (Nasdaq: CAMP), a clinical-stage biotechnology company developing a pipeline of regRNA-targeting therapeutics designed to upregulate gene expression with the goal of restoring healthy protein levels across a range of genetic diseases, today announced that management will present and be available for one-on-one meetings at the Piper Sandler 36^th Annual Healthcare Conference to be held at the Lotte New York Palace Hotel in New York City December 3^rd – 5^th, 2024.

Read more at globenewswire.com